Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome [2]

Journal of Dermatological Treatment

Volumn 15, Issue 2, 2004, Pages 120-121

  Vereecken, P ^a   Monsieur, E ^a   Petein, M ^a   Heenen, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; IMIQUIMOD; RETINOID;

ADULT; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER RISK; CANCER SURGERY; CASE REPORT; DRUG TOLERABILITY; FACE CANCER; HUMAN; LETTER; PRIORITY JOURNAL; SKIN IRRITATION;

ADMINISTRATION, CUTANEOUS; ADULT; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; FACE; HUMANS; MALE; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 1842663084     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630310017825     Document Type: Letter

References (6)

1. Gorlin RJ, Nevoid basal cell carcinoma syndrome. Dermatol Clin (1995) 13: 113-25.
2. Dahl MV, Imiquimod: a cytokine inducer. J Am Acad Dermatol (2002) 47(4): S205-208.
3. Micali G, De Pasquale R, Caltabiano R et al, Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. J Dermatol Treat (2002) 13: 123-7.
4. Kagy MK, Amonette R, The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg (2000) 26(6): 577-9.
5. Sockfleth E, Ulrich C, Hauschild A et al, Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol (2002) 12: 569-72.
6. Cowen E, Mercurio MG, Gaspari AA, An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream. J Am Acad Dermatol (2002) 47: S240-8.